Skip to content
No picture yet

Invokamet 150 mg / 1000 mg – DIN 02455455

Invokamet is Canagliflozin and Metformin Hydrochloride 150 mg / 1000 mg (tablet), sold in Canada. It is used for type 2 diabetes. It is supplied by Janssen Inc. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.

Sold in Canada

Canagliflozin and Metformin Hydrochloride 150 mg / 1000 mg

Brand
Invokamet
Strength
Canagliflozin 150 mg / Metformin Hydrochloride 1000 mg
Used for
Type 2 diabetes
Form
Tablet
Manufacturer
Janssen Inc
Drug class
Diabetes medicine (SGLT2 inhibitor)
Sold in
Canada
DIN
02455455

Source: Health Canada's Drug Product Database. Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Canagliflozin and Metformin pills and guides

What is Canagliflozin and Metformin used for?

Canagliflozin and Metformin is used for type 2 diabetes.

Medicine type
Diabetes medicine (SGLT2 inhibitor); diabetes medicine (biguanide)
Official uses from the US prescribing label

INVOKAMET

INVOKAMET is a combination of canagliflozin and metformin HCl immediate-release indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes mellitus.

INVOKAMET XR

INVOKAMET XR is a combination of canagliflozin and metformin HCl extended-release indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes mellitus.

Canagliflozin

Canagliflozin, when used as a component of INVOKAMET or INVOKAMET XR, is indicated in adults with type 2 diabetes mellitus to reduce the risk of:

  • Major adverse cardiovascular events (cardiovascular death, nonfatal myocardial infarction and nonfatal stroke) in adults with type 2 diabetes mellitus and established cardiovascular disease (CVD).
  • End-stage kidney disease (ESKD), doubling of serum creatinine, cardiovascular (CV) death, and hospitalization for heart failure in adults with type 2 diabetes mellitus and diabetic nephropathy with albuminuria greater than 300 mg/day.

Limitations of Use

INVOKAMET or INVOKAMET XR are not recommended for use to improve glycemic control in patients with type 1 diabetes mellitus.

From the FDA-approved label on DailyMed (published Aug 25, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your medicine? Check the box

  • The box or bottle shows DIN 02455455.
  • It names Invokamet, Canagliflozin and Metformin Hydrochloride 150 mg / 1000 mg.
  • A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.

Sold in Canada as Invokamet by Janssen Inc.

In Canada: prescription only.

Ingredients

Active: Canagliflozin, Metformin Hydrochloride

Other Canagliflozin and Metformin pills